Nice on CCIV - essentially your risk is about 60% downside, and from these nosebleeds, 200% upside (say 6 month timeframe). DMTK, it was the biggest no brainer idea I ever saw (bought common core at 5.03 and warrants at 0.065 immediately after the merger - just sold last of my warrants for 10000%, riding 1400 common long term). Simple put for those curious, its disruptive tech for melanoma testing. No need for biopsy, instead uses adhesive strip to take a sample. 99% accurate negatives and $260 less than cost of the biopsy. Only catch is convincing the dermatologists as they clearly make more money taking a chunk of skin - takes the patient to demand it IMH.
I will say, it seems to be a year ahead of schedule with price, but that is what covid has done to all stocks. Just keep in mind if you start positions - start small - add higher with cushion. It could easily correct 50% if the market were to go ugly, but it could just as easily go $100 in the next 3 months. I think it will be $400+ 2-3 years from now (or the equivalent split adjusted). Use EXAS as a comparison.